Skip to content

Discussion and research on precise clinical treatment strategies for diabetic macular edema

Discussion and research on precise clinical treatment strategies for diabetic macular edema

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000036434
Enrollment
Unknown
Registered
2020-08-23
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic macular edema

Interventions

Case series:Nil

Sponsors

Shanghai Sixth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients with type II diabetes aged >18 years; 2. Glycated hemoglobin (HbA1c) value <=10%; 3. There is no opacity of refractive medium and pupil reduction that affect fundus examination; 4. According to the 2019 AAO DR PPP diagnosis of macular edema involving the fovea (CI-DME), the thickness of the fovea measured by Heidelberg OCT is higher than the average normal +2SD (male 320um/female 305um), and it is determined that there is a clear DME.

Exclusion criteria

Exclusion criteria: (1) macular edema caused by other causes than diabetes; (2) cloudy ophthalmology due to cataract or other reasons; (3) retinal laser photocoagulation after receiving vitreoretinal surgery or retinal detachment within 3 months; (4) the target eye with proliferative diabetic retinopathy (PDR); (5) the target eye with vitreous hemorrhage within 2 months before screening; (6) the target eye with iris neovascularization; (7) Uncontrolled Hypertension or HbA1c> 12% poor glycemic control; (8) Cerebrovascular accident or MI within the last 3 months; (9) A history of anaphylaxis or allergy to sodium fluorescein, A history of allergy to protein preparations for treatment or diagnosis, allergy to two or more drugs and / or non-drug agents, or allergic diseases.

Design outcomes

Primary

MeasureTime frame
changes of intra-retinal layers;Zuì jia jiaozhèng shìlì 6/5000 Best corrected vision;

Countries

China

Contacts

Public ContactWu Qiang

Shanghai Sixth People's Hospital

wyansh@163.com+86 18930177422

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026